• Delivering Therapies that
    Enable a Healthier World

  • Inspired by Science

    LOTTE BIOLOGICS is dedicated to improving
    the lives of patients worldwide as a leading global CDMO.

  • Embracing Diversity

    LOTTE BIOLOGICS embraces diversity
    in the pursuit of global well-being.

  • Fostering Talent

    LOTTE BIOLOGICS fosters talent to
    lead global healthcare innovations.

  • Connecting Lives

    LOTTE BIOLOGICS connects people to
    bridge boundaries and promote sustainability.


With expertise that spans from development to clinical and commercial production,
LOTTE BIOLOGICS offers end-to-end CDMO services.


Introducing LOTTE BIOLOGICS' production facilities,
renowned for their top-tier quality and manufacturing capabilities.

Syracuse Bio Campus

(New York, USA)

With a manufacturing capacity of 40,000 liters of
Drug Substance, the Syracuse Bio Campus is also equipped for storage and quality control capabilities.

Songdo Bio Campus

(Incheon, South Korea)

LOTTE BIOLOGICS plans to operate a total of
three plants in Songdo, Incheon with a capacity of
360,000 liters starting from 2030.


Delivering the latest news from LOTTE BIOLOGICS.